Expert panel observations

Similar documents
Pseudoinvasion and how to deal with it

05/07/2018. What colorectal cancer screening is all about. Not so simple pathology: issues from the screening programme

12/7/2011. Pathological mimics of malignancy in the GI tract. Professor Neil A Shepherd President, British Division of the IAP

Colonic Polyp. Najmeh Aletaha. MD

The Kamal Ishak Lecture. The pathology of bowel cancer screening

The Kristin Henry Lecture. Colorectal cancer screening: extraordinary conundra for pathology

polyps of the colon and rectum

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

Surveying the Colon; Polyps and Advances in Polypectomy

Oesophagus and Stomach update dysplasia and early cancer

Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens

Pathology in Slovenian CRC screening programme:

Imaging Evaluation of Polyps. CT Colonography: Sessile Adenoma. Polyps, DALMs & Megacolon Objectives

References. GI Biopsies. What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD

Pathology in Slovenian CRC screening programme: Organisation and quality assurance. Snježana Frković Grazio and Matej Bračko

Adenoma and Malignant Colorectal Polyp: Pathological Considerations and Clinical Applications

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines

Large Colorectal Adenomas An Approach to Pathologic Evaluation

3/30/2017. Disclosure of Relevant Financial Relationships. Case 5: Polypoid mass in ulcerative colitis. Case 5. TC Smyrk

Update on Colonic Serrated (and Conventional) Adenomatous Polyps

Neoplastic Colon Polyps. Joyce Au SUNY Downstate Grand Rounds, October 18, 2012

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

S rectal polyps that show atypia, adenocarcinoma,

Rectal biopsy as an aid to cancer control in ulcerative colitis

Physician s Cognitive and Communication Failures Result in Cancer Treatment Delay

Management of pt1 polyps. Maria Pellise

5/2/2018. Low Grade Dysplasia of GI Tract. High Grade Dysplasia of GI Tract. Dysplasia in Gastrointestinal Tract: Practical Pearls and Issues

Patologia sistematica V Gastroenterologia Prof. Stefano Fiorucci. Colon polyps. Colorectal cancer

Diagnostic Difficulties Encountered Among Colorectal Polyps

Wendy L Frankel. Chair and Distinguished Professor

Hyperplastische Polyps Innocent bystanders?

05/07/2018. Organisation. The English screening programme what is happening? Organisation. Bowel cancer screening in the UK is:

The malignant colorectal polyp

NHS Bowel Cancer Screening Programme Guidance on reporting lesions. Public Health England leads the NHS Screening Programmes

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

White Rose Research Online URL for this paper: Version: Accepted Version

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

How to characterize dysplastic lesions in IBD?

A916: rectum: adenocarcinoma

Diagnostic accuracy of pit pattern and vascular pattern in colorectal lesions

General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS

Quality assurance in pathology in colorectal cancer screening and diagnosis European recommendations

Pathology perspective of colonic polyposis syndromes

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.

Rectal EMR: Techniques and Tips

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Advanced techniques for resection of large polyps. John G. Lee, MD February 2, 2018

FINAL HISTOLOGICAL DIAGNOSIS: Villo-adenomatous polyp with in-situ-carcinomatous foci (involving both adenomatous and villous component).

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

THE BIG, AWKWARD, FLAT POLYP THAT CAN T BE REMOVED WITH A (SINGLE) SNARE THE CASE FOR EMR AND ESD

Billing Guideline. Subject: Colorectal Cancer Screening Exams (Invasive Procedures) Effective Date: 1/1/14 Last revision effective 4/16

11/21/13 CEA: 1.7 WNL

Paris classification (2003) 삼성의료원내과이준행

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Barrett s Esophagus: Old Dog, New Tricks

Colonic adenomas-a colonoscopy survey

Polypoid lesions of the gastrointestinal tract

Endoscopic Submucosal Dissection ESD

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

OPEN ACCESS TEXTBOOK OF GENERAL SURGERY

The Paris classification of colonic lesions

BC CRC Update Malignant Polyp Who Needs Surgery

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN

What Every Pathologist Wants the GI Nurse to Know (and how you can help us help you)

Supplemental Digital Content 1. Endoscopic and histolological findings in INR and FR study subjects

what is the alternative mechanism of histogenesis? Aspects of the morphology of the adenomacarcinoma Morphology of the

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Is there justification for levels of polyp competency? Dr Roland Valori Gloucestershire Hospitals United Kingdom

Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care

Modern colonoscopy allows for both diagnosis and treatment

Histopathology: gastritis and peptic ulceration

EMR, ESD and Beyond. Peter Draganov MD. Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Florida

Dysplasia 4/19/2017. How do I practice Chromoendoscopy for Surveillance of Colitis? SCENIC: Polypoid Dysplasia in UC. Background

Adenoma to Carcinoma Pathway

Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema

Colon Cancer Screening & Surveillance. Amit Patel, MD PGY-4 GI Fellow

Greater Manchester & Cheshire Guidelines for Pathology Reporting of Oesophageal and Gastric Malignancy

Emerging Interventions in Endoscopy. Margaret Vance Nurse Consultant in Gastroenterology St Mark s Hospital

Factors for Endoscopic Submucosal Dissection in Early Colorectal Neoplasms: A Single Center Clinical Experience in China

Primary mucinous adenocarcinoma developing in an ileostomy stoma

12/7/2011. The reporting of colorectal cancer pathology: recent advances. Colorectal cancer resection specimens

In-situ and invasive carcinoma of the colon in patients with ulcerative colitis

Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

proposed Vienna classification of gastrointestinal

Synchronous and Subsequent Lesions of Serrated Adenomas and Tubular Adenomas of the Colorectum

Gastroenterology Tutorial

Formula One Study. Assessment criteria of pathological parameters. Ver.2. UK Japan Joint Study for Risk Factors of Lymph Node

How to treat early gastric cancer? Endoscopy

Endoscopic Mucosal Resection (EMR) & Endoscopic Submucosal Dissection (ESD)

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Transcription:

Expert panel observations Professor Neil A Shepherd Gloucester and Cheltenham, UK Gloucestershire Cellular Pathology Laboratory

Three big issues in BCSP pathology serrated pathology & what do we do about it expected polyp cancers (pt1 disease) & what we do about it expected the large adenomatous polyp of the sigmoid colon not expected (certainly not the amount nor the diagnostic difficulties) Gloucestershire Cellular Pathology Laboratory

Three big issues in BCSP pathology serrated pathology & what do we do about it expected polyp cancers (pt1 disease) & what we do about it expected the large adenomatous polyp of the sigmoid colon expected but not the amount nor the diagnostic difficulties Gloucestershire Cellular Pathology Laboratory

Epithelial misplacement in intestinal adenomatous polyps there are clues to the appropriate diagnosis site and size haemosiderin and accompaniment by lamina propria cytology similar to surface neoplasm large sigmoid colonic adenomatous polyps with such changes are selected into BCSP (they bleed)

Gloucestershire Cellular Pathology Laboratory

Gloucestershire Cellular Pathology Laboratory

The question Is this cancer in the submucosa or is it the benign phenomenon of epithelial misplacement? Gloucestershire Cellular Pathology Laboratory

Epithelial misplacement in adenomas 85% in sigmoid colon unusual in rectum (unless there has been previous meddling) same epithelium as surface, accompanied by lamina propria, haemosiderin deposition what about misplaced epithelium at the diathermy margin? intense pathological mimicry of invasive cancer Gloucestershire Cellular Pathology Laboratory

Epithelial misplacement vs invasive carcinoma There is a very important adage in pathology: why make two diagnoses when one will do?

Epithelial misplacement continuity Gloucestershire Cellular Pathology Laboratory

67M. BCSP. Sigmoid colonic polyp. Diathermy artefact disconcerts the changes of epithelial misplacement can be made to look much worse by diathermy artefact and it s at that margin Gloucestershire Cellular Pathology Laboratory

67M. BCSP. Sigmoid polyp. Previous biopsies and now polypectomy it s the company it keeps Gloucestershire Cellular Pathology Laboratory

BCSP polyps we need to keep our minds open. 62M. Sigmoid colonic polyp difficult endoscopic resection (left) site tattooed subsequent perforation and resection (left) do we allow epithelial misplacement in the muscularis propria? Yes we have now seen it several times

Enhancement of dysplastic change with inflammation and superficial ulceration

Review mechanisms for difficult BCSP/BSW cases BCSP/BSW local reporting pathologist Review by local/network BCSP/BSW GI pathologists Review by regional lead for BCSP/BSW Pathology National Expert Board Gloucestershire Cellular Pathology Laboratory

National Expert Board three pathologists you need a majority for this highly subjective and difficult assessment funded by BCSP organised by NAS cases are getting more and more difficult but we are learning Gloucestershire Cellular Pathology Laboratory

Original pathologist(s) Expert Board Pathologist A Expert Board Pathologist B Expert Board Pathologist C Mixed Cancer Cancer Cancer Benign Benign Benign Benign Cancer Cancer Cancer Cancer Equivocal Cancer Cancer Cancer Cancer Benign Benign Benign Equivocal Cancer Cancer Cancer Benign Benign Benign Benign Mixed Benign Benign Benign Cancer Benign Benign Benign Benign Cancer Cancer Cancer Equivocal Cancer Cancer Cancer Equivocal Cancer Cancer Cancer Equivocal Cancer Benign Cancer Benign Benign Benign Benign Cancer Benign Equivocal Equivocal Cancer Benign Benign Benign Equivocal Benign Benign Benign Equivocal Benign Equivocal Benign Cancer Benign Equivocal Suspicious

Original Pathologist(s) Expert Board Pathologist A Expert Board Pathologist B Expert Board Pathologist C Mixed Cancer Cancer Cancer Benign Benign Benign Benign Cancer Cancer Cancer Cancer Equivocal Cancer Cancer Cancer Cancer Benign Benign Benign Equivocal Cancer Cancer Cancer Benign Benign Benign Benign Mixed Benign Benign Benign Cancer Benign Benign Benign Benign Cancer Cancer Cancer Equivocal Cancer Cancer Cancer Equivocal Cancer Cancer Cancer Equivocal Cancer Benign Cancer Benign Benign Benign Benign Cancer Benign Equivocal Equivocal Cancer Benign Benign Benign Equivocal Benign Benign Benign Equivocal Benign Equivocal Benign Cancer Benign Equivocal Suspicious

What helps lamina propria accompaniment haemosiderin mucus lakes Gloucestershire Cellular Pathology Laboratory

What helps site: 87% in SC. Elsewhere if previous meddling. DC and other parts occasionally: rectum very rare unless meddling continuity between surface component and submucosal component (we live in a 3D world ) similar cytology and architecture muscular proliferation and mucosal prolapse changes evidence of acute necrosis Gloucestershire Cellular Pathology Laboratory

What helps.. why make two diagnoses? if there is classical misplacement in one area isolated glands budding desmoplastic reaction true vascular invasion (!) Gloucestershire Cellular Pathology Laboratory

Cancer Epithelial Epithelial Epithelial misplacement misplacement misplacement Misplacement of high grade dysplastic & non-neoplastic epithelium Previous biopsies and tattooing

Epithelial Epithelial Equivocal Epithelial misplacement misplacement misplacement

Descending colonic polyp Previous attempted removal Additional difficulty of morular change

Cancer Both: cancer Both: cancer Both: cancer and EM and EM and EM morphology different definite desmoplastic reaction definitely submucosal Gloucestershire Cellular Pathology Laboratory

Variable (5 GI Cancer but Equivocal Equivocal pathologists) very difficult

Cancer Epithelial Epithelial Epithelial misplacement misplacement misplacement low power lens, high power brain

Cancer Epithelial Epithelial Epithelial misplacement misplacement misplacement

Cancer Epithelial Epithelial Epithelial misplacement misplacement misplacement Epithelial destruction in EM because of inflammation & necrosis Gloucestershire Cellular Pathology Laboratory

Equivocal EM and intramucosal adenocarcinoma Superficial adenocarcinoma Can t make a firm diagnosis here

Malignant Epithelial Epithelial Epithelial misplacement misplacement misplacement

The results so far (December 2010) 65 cases referred to Expert Board (20 in 2009; 45 in 2010) Complete agreement between originating pathologist(s) and EB 17 Original diagnosis equivocal but EB diagnosis certain 22 Diametrically opposite diagnosis: originating pathologist(s) and EB 19 Both epithelial misplacement and cancer 4 Too difficult for EB 3 Gloucestershire Cellular Pathology Laboratory

Some questions is this the most extra-ordinary pathological phenomenon of all time? sudden high volume of very difficult cases: Jo/Jolene pathologist struggles; experts struggle all because of BCSP in the UK, are we too conservative when it comes to the diagnosis of colorectal cancer (thanks, Basil) (cf the Far East)? is cancer in continuity twixt its mucosal and submucosal components always, sometimes or never? is epithelial misplacement in continuity twixt its mucosal and submucosal components always, sometimes or never? Gloucestershire Cellular Pathology Laboratory

Practicalities this is effectively three second opinions it takes time we are aware of some 65 day breaches do you want a quick report or a good one? patient patience (and that of clinician and SSP) is the name of the game please get involved! Gloucestershire Cellular Pathology Laboratory

Practicalities unlikely to change immediate management more of a prognostic call for the patient (life insurance, etc) we advise a rapid return to the site & removal of anything remaining by EMR, etc we have no idea of the implication of epithelial misplacement at a margin and margin involvement alone is the most controversial aspect of the management of pt1 cancers Gloucestershire Cellular Pathology Laboratory

The team

Julietta Patnick and Richard Winder, BCSP Central

Gloucestershire Cellular Pathology Laboratory

Thanks for listening! Gloucestershire Cellular Pathology Laboratory